Controlled Release of Cyclosporine a from Biodegradable Amphiphilic Diblock Copolymer Sol-gel Drug Delivery System

Biodegradable sol-gel drug delivery systems containing cyclosporine A (CsA, cyclosporine) were prepared using methoxy (polyethylene glycol) and polyester diblock copolymers in aqueous solution. The diblock copolymers in aqueous solutions exhibited sol-gel transition behaviors with increasing temperature. The sol was formed by micelles. The micelle sizes of mPEG-PLGA and mPEG-PVLA were 70.8 nm and 67.1 nm, respectively. The sol-gel-sol transition phase diagrams were determined, as well as the variation of viscosity as a function of temperature. The maximum viscosities of the mPEG-PLGA and mPEG-PVLA gels were measured to be 11350 and 4420 cP, respectively. CsA was efficiently entrapped in both [methoxy (polyethylene glycol)-co-poly (lactic-co-glycolic acid)] (mPEG-PLGA) and [methoxy (polyethylene glycol)-co-poly (lactic-co-δ-valerolactic acid)) (mPEG-PVLA) sol-gel systems. Slow and sustained release of CaA was observed in vitro for both in situ gelling systems for 2 weeks.

[1]  So young Kim,et al.  Reverse Thermal Gelling PEG−PTMC Diblock Copolymer Aqueous Solution , 2007 .

[2]  Chaoliang He,et al.  In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[3]  D. Brocks,et al.  A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. San Román,et al.  Controlled release of cyclosporine from VP-HEMA copolymer systems of adjustable resorption monitorized by MEKC. , 2000, Biomaterials.

[5]  D. Brocks,et al.  Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. , 2005, Biomaterials.

[6]  T. Okano,et al.  Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Jan Feijen,et al.  Effect of comonomer hydrophilicity and ionization on the lower critical solution temperature of N-isopropylacrylamide copolymers , 1993 .

[8]  J. Doroshow,et al.  Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. , 2001, Blood.

[9]  A. Lavasanifar,et al.  Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[10]  H. Ahmadieh,et al.  Low dose cyclosporin-A therapy in Behçet's disease. , 1994, Journal of ocular pharmacology.

[11]  S. Cho,et al.  Preparation of methoxy poly(ethylene glycol)/polyester diblock copolymers and examination of the gel‐to‐sol transition , 2004 .

[12]  P. Emery,et al.  Clinical Use of Cyclosporin in Rheumatoid Arthritis , 2012, Drugs.

[13]  W. Dalton,et al.  Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J Verweij,et al.  Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.

[15]  S. Cho,et al.  Preparation of poly(ethylene glycol)-block-poly(caprolactone) copolymers and their applications as thermo-sensitive materials. , 2004, Journal of biomedical materials research. Part A.

[16]  Sung Wan Kim,et al.  Poly(D,L-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly (D,L-lactic acid-co-glycolic acid) triblock copolymer and thermoreversible phase transition in water. , 2002, Journal of biomedical materials research.

[17]  Sung Wan Kim,et al.  Novel Thermoreversible Gelation of Biodegradable PLGA-block-PEO-block-PLGA Triblock Copolymers in Aqueous Solution , 2001 .

[18]  J. Mestecky,et al.  Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Q. Fang,et al.  New Biodegradable Amphiphilic Block Copolymers of ε‐Caprolactone and δ‐Valerolactone Catalyzed by Novel Aluminum Metal Complexes , 2005 .

[20]  J. Curtis,et al.  Cyclosporine-induced nephrotoxicity: pathophysiology of decreased blood flow. , 1988, Transplantation proceedings.

[21]  N. Yoshimura,et al.  Dialysis and renal transplantation as renal replacement therapy for end-stage renal failure, with special reference to the ethical problems of living renal donation , 2001 .

[22]  W. Bennett,et al.  Chronic cyclosporine nephrotoxicity , 1998, Current opinion in nephrology and hypertension.